Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Light-chain nephropathy].

B Iványi1, J Nagy, G Varga

  • 1II. Belgyógyászati Klinika, Szent-Györgyi Albert Orvostudományi Egyetem Pathologiai Intézet, Szeged.

Orvosi Hetilap
|August 19, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral Burden of Sjögren Disease: A Systematic Review and Meta-analysis.

Journal of dental research·2026
Same author

Safety and efficacy of maxillomandibular fixation techniques: a network meta-analysis.

International journal of oral and maxillofacial surgery·2025
Same author

Phagocytic cell death leads to enhanced release of pro-inflammatory S100A12 in familial Mediterranean fever.

Molecular and cellular pediatrics·2023
Same author

Urinary tract infections in patients with multiple sclerosis and different methods of bladder evacuation.

Actas urologicas espanolas·2022
Same author

How effective is laparoscopic redo-antireflux surgery?

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2021
Same author

Characterization of oxidation of glutathione by cytochrome c.

Journal of bioenergetics and biomembranes·2021
Same journal

[Hungarian primary care: facts, problems and expectations].

Orvosi hetilap·2026
Same journal

[The role of obesity and weight reduction in obstructive sleep apnea].

Orvosi hetilap·2026
Same journal

[Mucinous cystic neoplasm of the liver].

Orvosi hetilap·2026
Same journal

[Towards the elimination of iodine deficiency in Hungary].

Orvosi hetilap·2026
Same journal

[Predictive factors of vocal cord paralysis following thyroid surgery].

Orvosi hetilap·2026
Same journal

[Letter to the editor].

Orvosi hetilap·2026
See all related articles

Renal light-chain disease, identified by monoclonal light-chain paraprotein deposition, causes proteinuria and progressive kidney failure. Clinicopathological analysis reveals interstitial fibrosis, tubular atrophy, and glomerular changes in affected patients.

Area of Science:

  • Nephrology
  • Pathology
  • Immunology

Context:

  • Light-chain deposition disease (LCDD) is a rare condition affecting the kidneys.
  • Pathological identification relies on monoclonal light-chain paraprotein deposits in renal tissue.
  • Associated conditions include multiple myeloma and non-tumorous plasma cell dyscrasia.

Purpose:

  • To investigate the clinicopathology of renal alterations in light-chain disease.
  • To correlate clinical presentation with morphological findings in six cases.
  • To characterize the nature of deposited paraprotein using electron microscopy.

Summary:

  • Six cases of light-chain disease exhibited renal involvement characterized by proteinuria and azotemia.
  • Monotypic light-chain paraprotein (kappa or lambda) was detected in renal basal membranes.

Related Experiment Videos

  • Electron microscopy confirmed the fine-granulated, electrodense nature of the deposits.
  • Morphological findings included interstitial fibrosis, tubular atrophy, arteriolar hyalinosis, and various glomerular alterations like nodular glomerulosclerosis.
  • Chronic renal insufficiency developed rapidly in most patients.

    • Impact:

    • This study enhances understanding of the clinicopathological spectrum of light-chain nephropathy.
    • It highlights the association between specific paraprotein deposits and renal dysfunction.
    • Findings contribute to the diagnosis and management of kidney disease in plasma cell disorders.